| 1 |
Sirisinha S. The potential impact of gut microbiota on your health: Current status and future challenges[J]. Asian Pac J Allergy Immunol, 2016, 34(4):249-264.
|
| 2 |
Blaser M, Bork P, Fraser C, et al. The microbiome explored: recent insights and future challenges[J]. Nat Rev Microbiol, 2013, 11(3):213-217.
|
| 3 |
Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease[J]. Nat Rev Immunol, 2009, 9(5):313-323.
|
| 4 |
张发明，李潘，崔伯塔，等. 粪菌移植：老故事与新未来[J]. 医学争鸣，2015, (1):17-22.
|
| 5 |
Zhang F, Luo W, Shi Y, et al. Should we standardize the 1，700-year-old fecal microbiota transplantation？[J]. Am J Gastroentero, 2012, 107(11):1755-1756.
|
| 6 |
Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis[J]. Surgery, 1958, 44(5):854-859.
|
| 7 |
Blum HE. The human microbiome[J]. Adv Med Sci, 2017, 62(2):414-420.
|
| 8 |
Cammarota G, Ianiro G, Bibbò S, et al. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation？[J]. Intern Emerg Med, 2014, 9(4):365-373.
|
| 9 |
van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile[J]. N Engl J Med, 2013, 368(5):407-415.
|
| 10 |
Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial[J]. Hepatology, 2017, 66(6):1727-1738.
|
| 11 |
Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial[J]. Lancet, 2017, 389(10075):1218-1228.
|
| 12 |
Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature, 2006, 444(7122):1027-1031.
|
| 13 |
Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections[J]. Am J Gastroenterol, 2013, 108(4):478-498; quiz 99.
|
| 14 |
Köpke M, Straub M, Dürre P. Clostridium difficile is an autotrophic bacterial pathogen[J]. PloS one, 2013, 8(4):e62157.
|
| 15 |
Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation[J]. Clin gastroenterol hepatol, 2011, 9(12):1044-1049.
|
| 16 |
Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(9):508-516.
|
| 17 |
Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice[J]. Gut, 2017, 66(4):569-580.
|
| 18 |
Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches[J]. Gastroenterology, 2017, 152(2):327-339. e4.
|
| 19 |
Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial[J]. Gastroenterology, 2015, 149(1):102-109. e6.
|
| 20 |
Rossen NG, Fuentes S, Van Der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis[J]. Gastroenterology, 2015, 149(1):110-118.e4.
|
| 21 |
Grinspan AM, Kelly CR. Fecal microbiota transplantation for ulcerative colitis: not just yet[J]. Gastroenterology, 2015, 149(1):15-18.
|
| 22 |
Cui B, Feng Q, Wang H, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn′s disease: safety, feasibility, and efficacy trial results[J]. J Gastroenterol Hepatol, 2015, 30(1):51-58.
|
| 23 |
Gordon H, Harbord M. A patient with severe Crohn′s colitis responds to faecal microbiota transplantation[J]. J Crohns Colitis, 2014, 8(3):256-257.
|
| 24 |
Kao D, Hotte N, Gillevet PM, et al. Fecal microbiota transplantation inducing remission in Crohn′s colitis and the associated changes in fecal microbial profile[J]. J Clin Gastroenterol, 2014, 48(7):625-628.
|
| 25 |
Zhang FM, Wang HG, Wang M, et al. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn′s disease[J]. World J Gastroenterol, 2013, 19(41):213-216.
|
| 26 |
Surrenti E, Rath DM, Pemberton JH, et al. Audit of constipation in a tertiary referral gastroenterology practice[J]. Am J Gastroenterol, 1995, 90(9):1471-1475.
|
| 27 |
Li N, Jiang J, Feng X, et al. Long-term follow-up of the Jinling procedure for combined slow-transit constipation and obstructive defecation[J]. Dis Colon Rectum, 2013, 56(1):103-112.
|
| 28 |
Khalif IL, Quigley EM, Konovitch EA, et al. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation[J]. Dig Liver Dis, 2005, 37(11):838-849.
|
| 29 |
Stecher B, Chaffron S, Kappeli R, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria[J]. PLoS Pathog, 2010, 6(1):1-15.
|
| 30 |
Zoppi G, Cinquetti M, Luciano A, et al. The intestinal ecosystem in chronic functional constipation[J]. Acta Paediatr, 2007, 87(8):836-841.
|
| 31 |
Tian H, Ding C, Gong J, et al. Treatment of slow transit constipation with fecal microbiota transplantation: A pilot study[J]. J Clin Gastroenterol, 2016, 50(10):865-870.
|
| 32 |
Tian H, Ge X, Nie Y, et al. Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial[J]. PloS one, 2017, 12(2):e0171308.
|
| 33 |
Tandon P, Madsen K, Kao D. Fecal microbiota transplantation for hepatic encephalopathy - ready for prime time？[J]. Hepatology, 2017, 66(6):1713-1715.
|
| 34 |
Bajaj JS. The role of microbiota in hepatic encephalopathy[J]. Gut microbes, 2014, 5(3):397-403.
|
| 35 |
Kao D, Roach B, Park H, et al. Fecal microbiota transplantation in the management of hepatic encephalopathy[J]. Hepatology, 2016, 63(1):339-340.
|
| 36 |
Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial[J]. Hepatology, 2017, 66(6):1727-1738.
|
| 37 |
Cowie BC, Carville KS, Maclachlan JH. Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority demanding action[J]. Antivir Ther, 2013, 18(8):953-954.
|
| 38 |
Yang HI, Lu SN, Liaw Y, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma[J]. N Engl J Med, 2002, 347(3):168-174.
|
| 39 |
Terrault NA, Bzowej N, Chang K, et al. AASLD guidelines for treatment of chronic hepatitis B[J]. Hepatology, 2016, 63(1):261-283.
|
| 40 |
Chou H, Chien W, Wu L, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota[J]. Proc Natl Acad Sci U S A, 2015, 112(7):2175-2180.
|
| 41 |
Knolle P, Uhrig A, Protzer U, et al. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine kupffer cells[J]. Hepatology, 1998, 27(1):93-99.
|
| 42 |
Huang L, Wohlleber D, Reisinger F, et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8＋ T cells and successful immunotherapy against chronic viral liver infection[J]. Nat Immunol, 2013, 14(6):574-583.
|
| 43 |
Ling Z, Liu X, Cheng Y, et al. Decreased diversity of the oral microbiota of patients with hepatitis B virus-induced chronic liver disease: A pilot project[J]. Sci Rep, 2015, 5:17098.
|
| 44 |
Ren YD, Ye ZS, Yang LZ, et al. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy[J]. Hepatology, 2017, 65(5):1765-1768.
|
| 45 |
Ley RE, Turnbaugh PJ, Klein S, et al. Human gut microbes associated with obesity[J]. Nature, 2006, 444(7122):1022-1023.
|
| 46 |
Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. Proc Natl Acad Sci U S A, 2004, 101(44):15718-15723.
|
| 47 |
Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143(4):913-916. e7.
|
| 48 |
Brandl K, Schnabl B. Intestinal microbiota and nonalcoholic steatohepatitis[J]. Curr Opin Gastroenterol, 2017, 33(3):128-133.
|
| 49 |
Haque TR, Barritt AS 4th. Intestinal microbiota in liver disease[J]. Best Pract Res Clin Gastroenterol, 2016, 30(1):133-142.
|
| 50 |
Haslam DB. Nonalcoholic steatohepatitis and the intestinal microbiota[J]. Hepatology, 2017, 65(2):401-403.
|
| 51 |
Zhou D, Pan Q, Shen F, et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota[J]. Sci Rep, 2017, 7(1):1529.
|
| 52 |
Mcelhanon BO, Mccracken C, Karpen S, et al. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis[J]. Pediatrics, 2014, 133(5):872-883.
|
| 53 |
Li Q, Han Y, Dy ABC, et al. The gut microbiota and autism spectrum disorders[J]. Front Cell Neurosci, 2017, 11:120.
|
| 54 |
Kang DW, Adams JB, Gregory AC, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study[J]. Microbiome, 2017, 5(1):10.
|
| 55 |
Couriel DR, Caldera H, Champlin RE, et al. Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management[J]. Cancer, 2004, 101(9):1936-1946.
|
| 56 |
Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy[J]. Nat Rev Immunol, 2012, 12(6):443-458.
|
| 57 |
Heidegger S, van den Brink MR, Haas T, et al. The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation[J]. Front Immunol, 2014, 5:337.
|
| 58 |
Yoshioka K, Kakihana K, Doki N, et al. Gut microbiota and acute graft-versus-host disease[J]. Pharmacol Res, 2017, 122:90-95.
|
| 59 |
Deeg HJ. How I treat refractory acute GVHD[J]. Blood, 2007, 109(10):4119-4126.
|
| 60 |
Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut[J]. Blood, 2016, 128(16):2083-2088.
|
| 61 |
Spindelboeck W, Schulz E, Uhl B, et al. Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease[J]. Haematologica, 2017, 102(5):e210.
|
| 62 |
Borody TJ, Leis S, Campbell J. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS)[J]. Am J Gastroenterol, 2011, 106:S352.
|
| 63 |
Malnick SD, Oppenheim A, Melzer E. Immune thrombocytopenia caused by fecal microbial transplantation in a patient with severe recurrent clostridium difficile Infection[J]. J Clin Gastroenterol, 2015, 49(10):888-889.
|
| 64 |
WHO, FAO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria[R]. Argentina, 2001.
|
| 65 |
Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea[J]. Expert Opin Biol Ther, 2012, 12(4):395-410.
|
| 66 |
Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora[J]. J Clin Gastroenterol, 2010, 44(8):551-561.
|
| 67 |
Tannock GW, Munro K, Harmsen HJ, et al. Analysis of the fecal microflora of human subjects consuming a probiotic product containing lactobacillus rhamnosus DR20[J]. Appl Environ Microbiol, 2000, 66(6):2578-2588.
|
| 68 |
Tyakht AV, Alexeev DG, Popenko AS, et al. Rural and urban microbiota: To be or not to be？[J]. Gut Microbes, 2014, 5(3):351-356.
|
| 69 |
Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of clostridium difficile infection in immunocompromised patients[J]. Am J Gastroenterol, 2014, 109(7):1065-1071.
|
| 70 |
Safety of fecal microbiota transplantation in patients with chronic colitis and immunosuppressive treatement[J]. J Crohns Colitis, 2015, 9(Suppl 1):S245-S246.
|
| 71 |
Solari PR, Fairchild PG, Noa LJ, et al. Tempered enthusiasm for fecal transplant[J]. Clin Infect Dis, 2014, 59(2):319.
|
| 72 |
Kump PK, Krause R, Steininger C, et al. Recommendations for the use of faecal microbiota transplantation " stool transplantation" ：consensus of the Austrian Society of Gastroenterology and Hepatology (OGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine[J]. Z Gastroenterol, 2014, 52(12):1485-1492.
|
| 73 |
Sokol H, Galperine T, Kapel N, et al. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation[J]. Dig Liver Dis, 2016, 48(3):242-247.
|
| 74 |
Tandon P, Madsen K, Kao D. Fecal microbiota transplantation for hepatic encephalopathy: Ready for prime time？[J]. Hepatology, 2017, 66(6):1713-1715.
|
| 75 |
Millan B, Laffin M, Madsen K. Fecal microbiota transplantation: beyond Clostridium difficile[J]. Curr Infect Dis Rep, 2017, 19(9):31.
|
| 76 |
Smits LP, Bouter KE, De Vos WM, et al. Therapeutic potential of fecal microbiota transplantation[J]. Gastroenterology, 2013, 145(5):946-953.
|
| 77 |
Smith M, Kassam Z, Edelstein C, et al. OpenBiome remains open to serve the medical community[J]. Nat Biotechnol, 2014, 32(9):867.
|
| 78 |
何植，张发明. 中华粪菌库的原则、方案和风险管理[J]. 胃肠病学，2017, 22(4):193-198.
|